Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Two Neoadjuvant Strategies With Bevacizumab in Locally Advanced Resectable Rectal Cancer: A Randomized, Non-Comparative Phase II Study

NCT00865189 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT00865189
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00865189 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Two Neoadjuvant Strategies With Bevacizumab in Locally Advanced Resectable Rectal Cancer: A Randomized, Non-Comparative Phase II Study
Lead sponsor
Hoffmann-La Roche
Phase
Phase 2
Overall status
Completed
Start date
October 23, 2007
Completion date
March 23, 2016
Enrollment
91 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer